Month: September 2020

Month: September 2020

FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients

By

Posted: September 29, 2020

– FDA has authorized randomized, controlled, double-blind, multicenter study on 352 patients TORONTO, ON / ACCESSWIRE / September 28, 2020 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE.CN) (“FSD Pharma” or the “Company“) today announced that the U.S. Food and Drug Administration (“FDA“) has authorized the initiation of a Phase 2 study for the use of FSD201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat COVID-19, the disease caused by the SARS-CoV-2 virus (the “FSD201 COVID-19 Trial“). The company is expected to start dosing patients in October 2020. We believe FSD201 may have the potential to address the over-exuberant inflammatory response characterized by COVID-19 infection that may lead to a cytokine storm and ultimately death. “Commencing a phase 2 clinical trial to treat hospitalized COVID-19 patients

Continue Reading “FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients”

Category: News & Events

Canntab Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tablets

By

Posted: September 22, 2020

TORONTO, Sept. 21, 2020 /CNW/ – Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the “Company” or “Canntab“), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is thrilled to announce that, pursuant to a filing made in March 2017, the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,772,837 to Canntab, titled “Modified Release Multi-Layer Tablet Cannabinoid Formulations. The term of the patent expires on March 15, 2038. Larry Latowsky, CEO of Canntab said “this is a major milestone that confirms our proprietary formulations are unique and differentiated from other product offerings in the global marketplace which will support a faster revenue stream as we begin production and distribution in the immediate future. This

Continue Reading “Canntab Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tablets”

Category: News & Events

Red Light Holland’s Science and Innovation Division, Scarlette Lillie Joins Medical Psychedelics Working Group with Leading Academics; Professor David Nutt and Professor Jo Neill

By

Posted: September 22, 2020

Toronto, Ontario–(Newsfile Corp. – September 17, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that Red Light Holland’s Science and Innovation division, Scarlette Lillie Science and Innovation (“Scarlette Lillie“), has joined the Medical Psychedelics Working Group (“MPWG“), a consortium of drug science experts, leading academics and researchers, policy specialists and industry partners. MPWG’s aim is to create a rational and enlightened approach to psychedelic research and clinical treatment. MPWG will explore innovation within the psychedelic space with a specific

Continue Reading “Red Light Holland’s Science and Innovation Division, Scarlette Lillie Joins Medical Psychedelics Working Group with Leading Academics; Professor David Nutt and Professor Jo Neill”

Category: News & Events

Gratomic Aims to Become a Cleaner Source of Graphite for North American Consumers

By

Posted: September 22, 2020

TORONTO, ON / ACCESSWIRE / September 3, 2020 / Gratomic Inc. (“GRAT” or the “Company”) (TSXV:GRAT)(OTC PINK:CBULF)(FRANKFURT:CB81) (WKN:A143MR) aims to become a cleaner graphite source for North American consumers and is pleased to announce the Company’s objective to process graphite in a clean and environmentally responsible manner. As the battery manufacturing industry becomes increasingly competitive, many electric vehicle battery manufacturers are currently forced towards choosing lesser environmentally friendly graphite options. In many cases, the mining and processing methods used can be unsafe and some have the potential to cause major pollution in neighbouring cities and towns. Alternatively, many electric vehicle battery manufacturers are turning to synthetic graphite sources, often created in labs from petroleum and biogas by-products, among other carbon sources.

Continue Reading “Gratomic Aims to Become a Cleaner Source of Graphite for North American Consumers”

Category: News & Events

Red Light Holland Announces Arrangement to Launch Sale of Psychedelic Truffle Microdosing Packs in the Netherlands

By

Posted: September 22, 2020

Toronto, Ontario–(Newsfile Corp. – September 2, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has solidified its arrangement with McSmart (as defined by the listing statement) for the launch of its previously announced Microdosing Packs through three Smart Shops operated by McSmart. The Microdosing Packs are anticipated to become available for purchase to consumers in the Netherlands before the end of September 2020, at the following Smart Shop locations: (i) two Tatanka locations, and (ii) the Headshop. In addition,

Continue Reading “Red Light Holland Announces Arrangement to Launch Sale of Psychedelic Truffle Microdosing Packs in the Netherlands”

Category: News & Events